Method Serum interleukin12 (IL12) level was determined by ELISA in 16 patients with primary hepatic carcinoma (PHC).
方法应用ELISA技术检测了16例原发性肝癌患者血清白细胞介素12的水平。
Objective: To investigate the change of hepatic function in the patients with primary hepatic carcinoma after operation.
目的：探讨原发性肝癌病人手术前后肝功能变化规律。
Objective To study the infection rate of HBV and HCV in patients with primary hepatic carcinoma (PHC) or other malignant tumour.
目的：研究原发性肝癌与其他恶性肿瘤患者HBV及H CV感染率。
Objective To investigate correlation of abnormal sublingual collaterals in patients with primary hepatic carcinoma and portal venous flow alteration.
目的：探讨原发性肝癌异常舌下络脉的特征与门静脉血流动力学变化的相关性。
Objective: To study changes of GPDA activity in serum and hepatic tissues in patients with primary hepatic carcinoma and explore the clinical significance.
目的：为了解人肝癌组织及血清中gpda活性变化，探讨其临床意义。
Objective: To study changes of GPDA isoenzyme in serum and hepatic tissues in patients with primary hepatic carcinoma and explore the clinical significance.
目的：为了解人肝癌组织及血清中甘氨酰脯氨酸二肽氨基肽酶(GPDA)同工酶变化，探讨其临床意义。
Objective To analyze the influence of diagnosis and surgical treatment of spontaneous rupture and hemorrhage in patients with primary hepatic carcinoma(PHC) on prognosis.
目的探讨原发性肝癌（PHC）自发破裂出血的诊治特点及预后。
Objective: to evaluate the effect and toxicity of intra-arterial hepatic administration magnetically targeted carrier doxorubicin (MTC-DOX) with primary hepatocellular carcinoma patients.
目的：观察磁导向载体阿霉素(MTC DOX)肝动脉介入治疗原发性肝癌的有效性和安全性。
Purpose: To observe the vascular and blood flow changes of portal vein (PV) and hepatic artery (ha) in patients with primary liver carcinoma (PHC).
目的：观察原发性肝癌(PHC)患者的门静脉(PV)、肝动脉(HA)的血管和血流变化。
ObjectiveTo explore the clinical feature of abnormal glucose metabolism in the patients with paraneoplastic syndrome (PNS) of primary hepatic carcinoma (PHC).
目的探讨原发性肝癌(PHC)伴癌综合征(PNS)患者的糖代谢异常的临床特征。
PURPOSE to assess the value of an improved regimen of granisetron in the prophylaxis of hepatic artery chemo embolization induced nausea and vomiting in patients with primary hepatocellular carcinoma.
目的探讨康泉改进方案预防原发性肝癌化疗栓塞术后恶心、呕吐的临床应用价值。
PURPOSE to assess the value of an improved regimen of granisetron in the prophylaxis of hepatic artery chemo embolization induced nausea and vomiting in patients with primary hepatocellular carcinoma.
目的探讨康泉改进方案预防原发性肝癌化疗栓塞术后恶心、呕吐的临床应用价值。
应用推荐